Page 6 - Inflarx Commitment Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inflarx commitment program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inflarx Commitment Program Today - Breaking & Trending Today

InflaRx Target of Unusually High Options Trading (NASDAQ:IFRX)

InflaRx (NASDAQ:IFRX – Get Rating) saw unusually large options trading activity on Wednesday. Investors purchased 5,858 call options on the stock. This is an increase of approximately 2,983% compared to the typical daily volume of 190 call options. Institutional Investors Weigh In On InflaRx Several hedge funds have recently added to or reduced their stakes […] ....

Renfeng Guo , Nicolas Fulpius , Niels Christoph Riedemann , Virtu Financial , Raymond James Financial Services Advisors Inc , Renaissance Technologies , Invesco Ltd , Get Rating , James Financial Services Advisors , Montreal Can , Inflarx Daily , Nasdaq Ifrx ,

InflaRx Stock Surges 65% On FDA EUA For Gohibic For Treatment Of Critically Ill COVID-19 Patients

Shares of InflaRx N.V. (IFRX) are surging nearly 65% on Wednesday morning after it received the U.S. Food and Drug Administration's Emergency Use Authorization for Gohibic (vilobelimab) for treatment of critically ill COVID-19 patients. ....

Drug Administration Emergency Use Authorization For Gohibic , Drug Administration , Emergency Use Authorization , Biologics License Application ,

InflaRx N : CONVENING NOTICE - Form 6-K

CONVENING NOTICE

This is the convening notice for the 2023 annual general meeting of shareholders of InflaRx N.V. to be held on April 26, 2023. | April 5, 2023 ....

Noord Holland , Hege Hellstrom , Discussion Of The Company , Instruction To Ernst Young Accountants , Young Accountants , Record Date , Meeting Rights , Beneficial Owners , Attendance Notice , Cut Off Date , Inflarxnv Stock Exchange , Press Release , Pril Ifrx Nl0012661870 ,

InflaRx's Gohibic Gets Emergency Use Authorization from FDA for Covid-19 Hospitalized Patients

By Denny Jacob

InflaRx NV on Tuesday said Gohibic, a monoclonal anti-human complement factor C5a antibody, was granted emergency use authorization by the Food and Drug Administration.

The. | April 4, 2023 ....

Niels Riedemann , Denny Jacob , European Medicines Agency , European Committee For Medicinal Products Human , Drug Administration , European Committee , Medicinal Products , Human Use , European Medicines , Executive Niels Riedemann , Dow Jones , Inflarxnv Stock Exchange , Press Release , Rug Ifrx Nl0012661870 ,

InflaRx (NASDAQ:IFRX) Short Interest Update

InflaRx (NASDAQ:IFRX – Get Rating) was the target of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 203,900 shares, a decrease of 12.5% from the February 28th total of 233,000 shares. Currently, 0.5% of the shares of the company are sold short. Based […] ....

Niels Christoph Riedemann , Renfeng Guo , Nicolas Fulpius , Renaissance Technologies , Millennium Management , Invesco Ltd , Raymond James Financial Services Advisors Inc , Inflarx Company Profile , Get Rating , Montreal Can , Raymond James Financial Services Advisors , James Financial Services Advisors , Inflarx Daily , Nasdaq Ifrx ,